Psoriatic Arthritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis
OSAKA Japan and CAMBRIDGE, Massachusetts, November 7, 2023 – Takeda (TSE:4502/NYSE:TAK) today announced that the company will present positive results from its randomized, double-blind, placebo-controlled, Phase 2b trial evaluating... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 7, 2023 Category: Pharmaceuticals Source Type: clinical trials

Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients
Conditions: Psoriatic Arthritis; Psoriasis Interventions: Behavioral: Fatigue assessment; Behavioral: Quality of life assessment; Other: Assess severity of psoriatic arthritis; Other: Assess severity of cutaneous psoriasis Sponsors: Centre Hospitalier Henri Duffaut - Avignon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Conditions: Juvenile Psoriatic Arthritis Interventions: Drug: Adalimumab; Drug: Risankizumab Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
Conditions: Psoriasis and Psoriatic Arthritis Interventions: Drug: Apremilast 30 mg Tablets Sponsors: Humanis Sagl ık Anonim Sirketi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in the Arthritis Hand
Conditions: Arthritis, Psoriatic; Arthritis, Rheumatoid; Deformity, Hand; Limitation, Mobility; Hand Arthritis; Hand Deformity Interventions: Other: Digital Rehabilitation; Other: Conventional Rehabilitation Sponsors: Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials

Cohort Project of Patients With Inflammatory Rheumatism
Conditions: Rheumatoid Arthritis; Spondyloarthritis, Axial; Psoriatic Arthritis Interventions: Other: no intervention Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
Topline Results for TAK-279 Show that a Significantly Greater Proportion of Psoriatic Arthritis Patients Achieved at Least an ACR20 Response Compared to Placebo at Week 121 Based on the Positive Results, Takeda Intends to Initiate a Phase 3 Study... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 11, 2023 Category: Pharmaceuticals Source Type: clinical trials

Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis
Condition: Psoriatic Arthritis Intervention: Sponsor: Women's College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials